Expression of asparagine synthetase predicts in vitro response to l-asparaginase in canine lymphoid cell lines

Leukemia and Lymphoma

Volumn 55, Issue 6, 2014, Pages 1357-1365

  Smallwood, Tangi L ^a   Small, George W ^a   Suter, Steven E ^b   Richards, Kristy L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Asparagine synthetase; Comparative oncology; l asparaginase; Lymphoma; Methylation

Indexed keywords

ASPARAGINASE; ASPARTATE AMMONIA LIGASE; AZACITIDINE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; DNA METHYLATION; DOG; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; LYMPHOCYTE; LYMPHOMA; METABOLISM; MORTALITY; TUMOR CELL LINE;

ANIMALS; ASPARAGINASE; ASPARTATE-AMMONIA LIGASE; AZACITIDINE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DNA METHYLATION; DOGS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; LYMPHOCYTES; LYMPHOMA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84901381289     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.842980     Document Type: Article

References (37)

1. Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 2004;84:1-12. (Pubitemid 39625035
2. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013
3. Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008;8:147-156. (Pubitemid 351161319
4. Kilberg MS, Hutson SG, Laine RO. Amino acid-regulated gene expression in eukaryotic cells. FASEB J 1994;8:13-19. (Pubitemid 24047406
5. Richards NG, Kilberg MS. Asparagine synthetase chemotherapy. Annu Rev Biochem 2006;75:629-654. (Pubitemid 44118046
6. Sorenmo K, Overley B, Krick E, et al. Outcome and toxicity associated wiTha dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol 2010;8:196-208
7. Clarkson B, Krakoff I, Burchenal J, et al. Clinical results of treatment wiThE. coli L-Asparaginase in adults wiThleukemia, lymphoma, and solid tumors. Cancer 1970;25:279-305
8. Lorenzi PL, Reinhold WC, Rudelius M, et al. Asparagine synthetase as a causal, predictive biomarker for L-Asparaginase activity in ovarian cancer cells. Mol Cancer Ther 2006;5:2613-2623. (Pubitemid 44848988
9. Lorenzi PL, Llamas J, Gunsior M, et al. Asparagine synthetase is a predictive biomarker of L-Asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther 2008;7:3123-3128
10. Krejci O, Starkova J, Otova B, et al. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-Asparaginase in TEL/AML1-positive leukaemic cells. Leukemia 2004;18:434-441. (Pubitemid 38425856
11. Story MD, Voehringer DW, Stephens LC, et al. L-Asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharamcol 1993;32:129-133. (Pubitemid 23131932
12. Ueno T, Ohtawa K, Mitsui K, et al. Cell cycle arrest and apoptosis of leukemia cells induced by L-Asparaginase. Leukemia 1997;11: 1858-1861. (Pubitemid 27485130
13. Li BS, Gu LJ, Luo CY, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L-Asparaginase. Leukemia 2006;20:2199-2201. (Pubitemid 44782855
14. Su N, Pan YX, Zhou M, et al. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines. Pediatr Blood Cancer 2008;50:274-279
15. Abbatiello SE, Pan YX, Ahou M, et al., Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. J Proteom 2008;71:61-70. (Pubitemid 351697862
16. Appel IM, den Boer ML, Meijerink JP, et al. Up-regulation of asparagine synthetase expression is not linked to the clinical response to L-Asparaginase in pediatric acute lymphoblastic leukemia. Blood 2006;107:4244-4249. (Pubitemid 43801347
17. Nakaichi M, Taura Y, Kanki M, et al. Establishment and characterization of a new canine B-cell leukemia cell line. J Vet Med Sci 1996;58:469-471. (Pubitemid 126467462
18. Suter SE, Small GW, Seiser EL, et al. FLT3 mutations in canine acute lymphocytic leukemia. BMC Cancer 2011;11:38
19. Momoi Y, Okai Y, Watari T, Goitsuka R, Tsuimoto H, Hasegawa A. Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Vet Immunol Immunopathol. 1997;59:11-20. (Pubitemid 28044508
20. KisseberThWC, Nadella MV, Breen M, et al. Anovel canine lymphoma cell line: A translational and comparative model for lymphoma research. Leuk Res 2007;31:1709-1720. (Pubitemid 350051400
21. Suter SE, Chein MB, von Messling V, et al. In vitro canine distemper virus infection of canine lymphoid cells: A prelude to oncolytic therapy for lymphoma. Clin Cancer Res 2005;11:1579-1587
22. Seiser EL, Thomas R, Richards KL, et al. Reading between the lines: Molecular characterization of five widely utilized canine lymphoid tumor cell lines. Vet Comp Oncol 2011;11:30-50
23. RDevelopment Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012
24. de Hoon MJ, Imoto S, Nolan J, et al. Open source clustering software. Bioinformatics 2004;20:1453-1454. (Pubitemid 38931415
25. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci 1998;95:14863-14868. (Pubitemid 29003722
26. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004;20:3246-3248. (Pubitemid 39619217
27. Colella S, Shen L, Baggerly KA, et al. Sensitive and quantitative universal Pyrosequencing□ methylation analysis of CpG sites. Biotechniques 2003;35:146-150. (Pubitemid 36828724
28. Avramis V, Tiwari PN. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomed 2006;1:241-254
29. Avramis V. Asparaginases: Biochemical pharmacology and modes of drug resistance. Anticancer Res 2012;32:2423-2438
30. Yu M, Henning R, Walker A, et al. L-Asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med 2012;16:2369-2378
31. Peng H, Shen N, Qian L, et al. Hypermethylation of CpG islands in the mouse asparagine synthetase gene: Relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells. Br J Cancer 2001;85:930-935. (Pubitemid 33010564
32. Worton KS, Kerbel RS, Andrulis IL. Hypomethylation and reactivation of the asparagine synthetase gene inducced by L-Asparaginase and ethyl methanesulfonate. Cancer Res 1991;51: 985-989
33. Akagi T, Yin D, Kawamata N, et al. Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells. Leukemia 2006;20:1303-1306. (Pubitemid 43905840
34. Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by l-Asparaginase. Br J Haematol 2005; 130:860-868. (Pubitemid 43899727
35. Matsumoto Y, Nomura K, Kanda-Akano Y, et al. Successful treatment wiThErwinia L-Asparaginase for recurrent natural killer/T cell lymphoma. Leuk Lymphoma 2003;44:879-882. (Pubitemid 36410998
36. Rassnick KM, McEntee MC, Erb HN, et al. Comparison of 3 protocols for treatment after induction of remission in dogs wiThlymphoma. J Vet Intern Med 2007;21:1364-1373. (Pubitemid 350303644
37. Iwamoto S, Mihara K, Downing JR, et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007;117:1049-1057. (Pubitemid 46556761